MICRO-X LIMITED (MX1)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MX1 - MICRO-X LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.17

29 Sep
2022

0.000

OPEN

$0.18

0.000

HIGH

$0.18

333,309

LOW

$0.17

TARGET
$0.33 94.1% upside
OTHER COMPANIES IN THE SAME SECTOR
ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . CAT . VHT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . PEB . AT1 . CBL .
FNARENA'S MARKET CONSENSUS FORECASTS
MX1: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx - 3.7 - 2.2 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx-3.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx9.0 M
Book Value Per Share xxxxxxxxxxxxxxx4.2
Net Operating Cash Flow xxxxxxxxxxxxxxx-18.1 M
Net Profit Margin xxxxxxxxxxxxxxx-190.51 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx-64.04 %
Return on Invested Capital xxxxxxxxxxxxxxx-53.89 %
Return on Assets xxxxxxxxxxxxxxx-45.00 %
Return on Equity xxxxxxxxxxxxxxx-64.04 %
Return on Total Capital xxxxxxxxxxxxxxx-61.15 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-19.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

29/09/2022

1

Speculative Buy

$0.33

94.12%

Following two positive announcements by Micro-X, Morgans now sees a cash runway through to 2024 when sales momentum in Europe and Argus sales should kick in.

Varex Corporation, the largest independent manufacturer of x-ray technology components, has taken an equity stake in Micro-X .

Varex will also pay $7.5m (via installments/not yet included in broker's forecast) to use Micro-X's NEX technology in the field of multi-beam x-ray tube.

Separately, the US Department of Homeland Security has extended the Checkpoint project which includes an additional US$0.4m in funding.

The Speculative Buy rating is maintained, while the target price falls to $0.33 from $0.36 due to the equity placement.

FORECAST
Morgans forecasts a full year FY23 dividend of 0.00 cents and EPS of minus -2.20 cents.
Morgans forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.10 cents.

MX1 STOCK CHART